Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer

Conditions:   TN ER-/PR-/HER2- Breast Cancer;   Triple Negative Breast Cancer;   HER2-positive Breast Cancer;   ERany/PRany/HER2+ Breast Cancer Intervention:   Radiation: Standard Trimodality Breast Imaging Sponsor:   Masonic Cancer Center, University of Minnesota Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials